載入...
Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing–Remitting Multiple Sclerosis Patients
Autologous hematopoietic stem cell transplantation (AHSCT) has been used in the treatment of highly active multiple sclerosis (MS) for over two decades. It has been demonstrated to be highly efficacious in relapsing–remitting (RR) MS patients failing to respond to disease-modifying drugs (DMDs). AHS...
Na minha lista:
| 發表在: | Neurol Ther |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer Healthcare
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7606396/ https://ncbi.nlm.nih.gov/pubmed/32548740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40120-020-00200-9 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|